AATCC Review Article Describes Stay-Fresh(R) Antimicrobial Technology
10 September 2013 - 2:05PM
Marketwired
GAINESVILLE, FL--(Marketwired - September 10,
2013) - Quick-Med Technologies, Inc. (OTCQB: QMDT), a
life sciences company that is developing innovative technologies
for the healthcare and consumer markets, announced today that its
Stay Fresh technology is
featured in AATCC Review (http://www.aatcc.org/media/), the journal
of the American Association of Textile Colorist and
Chemists. The AATCC is a not for profit association of textile
professionals, and a leader in development of standards and for
knowledge about textiles and textile processing.
"We are very pleased that AATCC elected to publish this
scientific article detailing our peroxide based antimicrobial
technology. Our Stay Fresh technology can add functionality
and value to textiles, as well as preserve hygiene and
freshness. It also protects textiles from microbial
degradation during all parts of their life cycle -- from production
and inventory preservation through to providing added comfort for
the end user," said Bernd Liesenfeld, Quick-Med's President and
lead author for the publication. The article details testing
showing strong antimicrobial efficacy even after multiple
launderings, and presents substantiating analytical testing data
that document how the peroxide functionalization provides superior
durability compared to many other antimicrobial finishes.
About Stay
Fresh
Stay Fresh is Quick-Med's
newest technology platform. This technology is based on
hydrogen peroxide -- a well known consumer antimicrobial product
that is commonly used in households for disinfecting cuts, scrapes,
toothbrushes, etc. Due to its green credentials, Hydrogen Peroxide
is also seeing increasing use in household cleaning products
targeting environmentally conscious consumers. Hydrogen
peroxide is also produced by human cells to combat invasive
bacteria, and is a naturally occurring preservative component of
milk and honey. EPA has registered Stay Fresh to be utilized to protect a
broad selection of treated goods for consumer use, including
textiles, decorative fabrics, and functional fabrics such as
filters and carpets. FDA has also granted clearance to market
an antibacterial medical textile based on Stay Fresh Technology. The
Stay Fresh technology
offerings provided by Quick-Med are expanding continuously, with
development of additional applications including antimicrobial
surface treatments, and superabsorbent antimicrobial powders to
complement the range of products that are already cleared for
consumer use under EPA or FDA jurisdiction.
About Quick-Med Technologies,
Inc.
Quick-Med Technologies, Inc. is a life sciences company that is
developing and commercializing proprietary, broad-based
technologies for the consumer and healthcare markets. The
Company's NIMBUS®
technology is the first FDA-cleared, non-leaching antimicrobial
technology available in a wound dressing. Its Stay Fresh® technology provides highly
durable antimicrobial protection for apparel and other textile
applications, with consumer applications of Stay Fresh Technology having EPA
registration for the treated articles, as well as an FDA clearance
for an antibacterial medical textile product. Quick-Med
develops antimicrobial technologies to promote public health,
safety and comfort. For more information, see:
www.quickmedtech.com.
© 2013 Quick-Med Technologies, Inc. All rights
reserved. NIMBUS®, and
Stay Fresh® are registered trademarks of
Quick-Med Technologies, Inc.
Forward-looking statements
(statements which are not historical facts) in this release are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. For this purpose, any
statements contained in this release that are not statements of
historical fact may be deemed to be forward-looking statements.
Without limiting the generality of the foregoing, words such as
"may", "will", "to", "expect", "plan", "believe", "anticipate",
"intend", "could", "would", "estimate", and/or "continue" or the
negative or other variations thereof or comparable terminology are
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the
Company's filings with the Securities and Exchange Commission
("SEC"), which may be accessed at the SEC's Edgar System at
www.sec.gov.
CONTACT: Quick-Med Technologies Bernd Liesenfeld,
President (352) 379-0611
bliesenfeld@quickmedtech.com
Quick Med Technologies (CE) (USOTC:QMDT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Quick Med Technologies (CE) (USOTC:QMDT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
